Additional file 1 of Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial

Zheng, Jinping; Baldi, Simonetta; Zhao, Li; Li, Huiping; Lee, Kwan-Ho; Singh, Dave; Papi, Alberto; Grapin, Frédérique; Guasconi, Alessandro; Georges, George

doi:10.6084/m9.figshare.14274747.v1

12931_2021_1683_MOESM1_ESM.docx (353.71 kB)

Additional file 1 of Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial

journal contribution

posted on 2021-03-24, 05:20 authored by Jinping Zheng, Simonetta Baldi, Li Zhao, Huiping Li, Kwan-Ho Lee, Dave Singh, Alberto Papi, Frédérique Grapin, Alessandro Guasconi, George Georges

Additional file 1. Supplementary methods and results supporting the main body of the manuscript.

Funding

Chiesi Farmaceutici

History

Usage metrics

Keywords

Triple inhalation therapy Chronic obstructive pulmonary disease Chronic bronchitis Airway obstruction Extrafine

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial

Funding

Chiesi Farmaceutici

History

Usage metrics

Categories

Keywords

Licence

Exports